Telemonitoring in patients with chronic heart failure

Actuality. High risk of hospitalisation and death in patients with heart failure highlight the importance of developing methods to moni‑ tor weight, diuresis, heart rate and other parameters and provide the physicians with an ability to change the therapy immediately if needed. The aim of this work is an analysis of clinical trials which investigate telemonitoring in patients with heart failure. Discussion. The Cochrane meta-analysis is also discussed in this work. Main conclusions. Our analysis showed that there is no consistency among trials. Not all trials have demonstrated that telemonitoring can reduce the risk of death and heart failure hospitalisations. Potentials explanations are lack of compliance with systems which didn’t include the direct contact between the patient and the caregivers, using parameters with low sensitivity in some of the methods and including of stable patients in some of the studies. It is also seeming that effect of telemonitoring is low in regions with existing programs to treat heart failure.

1. Giordano A, Scalvini S, Zanelli E, Corrà U, G.L. L, Ricci VA et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. International Journal of Cardiology. 2009;131(2):192–9. DOI: 10.1016/j.ijcard.2007.10.027

2. Belenkov Yu.N., Mareev V.Yu. The treatment of congestive heart failure in XXI century: questions and lessons of evidence based medicine. Kardiologiia. 2008;48 (2):6–16.

3. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M et al. Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients with Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study. Circulation. 2011;123(17):1873–80. DOI: 10.1161/ CIRCULATIONAHA.111.018473

4. Mareev Yu.V., Gerasimova V.V., Goriunova T.V., Petrukhina A.A., Danielian M.O., Kapanadze L.G. et al. Factors defining the prognosis in chronic heart failure: role of the QRS width and morphology. Russian Heart Failure Journal. 2012;13 (5):255–66.

5. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z et al. Telemonitoring in patients with heart failure. The New England Journal of Medicine. 2010;363(24):2301–9. DOI: 10.1056/ NEJMoa1010029

6. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. American Heart Journal. 2007;154(2):260–6. DOI: 10.1016/j. ahj.2007.01.041

7. Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews. 2015;10:CD007228. DOI: 10.1002/14651858. CD007228.pub3

8. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). European Journal of Heart Failure. 2013;15(7):808–17. DOI: 10.1093/eurjhf/hft050

9. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients with Heart Failure: The Bet¬¬ter Effectiveness After Transition–Heart Failure (BEATHF) Randomized Clinical Trial. JAMA Internal Medicine. 2016;176(3):310–8. DOI: 10.1001/jamainternmed.2015.7712

10. Polyakov D.S., Fomin I.V., Valikulova F.Yu., Vaisberg A.R., Kraiem N., Badin Yu.V. et al. The EPOCH-CHF epidemiological program: decompensated chronic heart failure in real-life clini cal practice (EPOCH-D-CHF). Russian Heart Failure Journal. 2016;17 (5):299–305. DOI: 10.18087/ rhfj.2016.5.2239

11. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treat ment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/ eurheartj/ehw128

12. Gilotra NA, Shpigel A, Okwuosa IS, Tamrat R, Flowers D, Russell SD. Patients commonly believe their heart failure hospitalizations are preventable and identify worsening heart failure, nonadherence, and a knowledge gap as reasons for admission. Journal of Cardiac Failure. 2017;23(3):252–6. DOI: 10.1016/j.cardfail.2016.09.024

13. Lynga P, Persson H, Hägg-Martinell A, Hägglund E, Hagerman I, Langius-Eklöf A et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. European Journal of Heart Failure. 2012;14(4):438–44. DOI: 10.1093/eur jhf/hfs023

14. Boytsov S.A., Komkov D.S., Val’denberg A.V., Rovkina E.I., Shipachev K.V., Grishanova T.G. Methodology of distant dis pensary observation. Supplement for metodologic recomden dations: Dispensary observation of patients with chronic noninfection deseases and patients with high rish of this desease. – M.: NMRCPM MH RF;2016. – 21 p. ISBN 978-5-600-01496-1

15. Mareev V.Yu., Begrambekova Yu.L., Danielyan M.O., Ageev F.T., Gilyarevskiy S.R., Belenkov Yu.N. et al. What questions are asked and answered by studies of non-drug treatment in patients with heart failure. Lessons from the CHANCE study. Russian Heart Failure Journal. 2014;15 (6):383–96.

16. Ageev F.T., Mareev V.Yu., Seredenina E.M., Belenkov Yu.N. Prospects for introducing specialized forms of active outpatient management in patients with heart failure: structure, methodology and preliminary results of the Russian program «SHANS». Russian Heart Failure Journal. 2004;5 (6):268–71.

17. Mortara A, Pinna GD, Johnson P, Maestri R, Capomolla S, La Rovere MT et al. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure). European Journal of Heart Failure. 2009;11(3):312–8. DOI: 10.1093/eurjhf/hfp022

18. Belenkov Yu.N., Ageev F.T., Banshikov G.T., Volkova E.G., Gilyarevskiy S.R., Donova I.G. et al. Effect of specialized forms of active out-patient management on the functional status, quality of life and hemodynamic parameters in patients with advanced heart failure. Results of the Russian Program «CHANCE». Russian Heart Failure Journal. 2007;8 (3):112–6.

19. Boyne JJJ, Vrijhoef HJM, Crijns HJGM, De Weerd G, Kragten J, Gorgels APM et al. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. European Journal of Heart Failure. 2012;14(7):791–801. DOI: 10.1093/eurjhf/hfs058

20. Rebrov A.P., Kosheleva N.A. Effect of therapeutic training and active outpatient management on clinical state and cardiovascu lar complications in patients with chronic heart failure (three year follow-up). Rational Pharmacotherapy in Cardiology. 2011;7 (3):275–87.

21. Soran OZ, Piña IL, Lamas GA, Kelsey SF, Selzer F, Pilotte J et al. A Randomized Clinical Trial of the Clinical Effects of Enhanced Heart Failure Monitoring Using a Computer-Based Telephonic Monitoring System in Older Minorities and Women. Journal of Cardiac Failure. 2008;14(9):711–7. DOI: 10.1016/j.card fail.2008.06.448

22. Roccaforte R, Demers C, Baldassarre F, K. Teo K, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A metaanalysis. European Journal of Heart Failure. 2005;7(7):1133–44. DOI: 10.1016/j.ejheart.2005.08.005

23. Vasilevskis EE, Kripalani S, Ong MK, Rosenthal JT, Longnecker DE, Harmon B et al. Variability in Implementation of Interventions Aimed at Reducing Readmissions Among Patients with Heart Failure: A Survey of Teaching Hospitals. Academic Medicine. 2016;91(4):522–9. DOI: 10.1097/ACM.0000000000000994

24. GESICA Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005;331(7514):425. DOI: 10.1136/bmj.38516.398067.E0

25. Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B-A et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. The Lancet. 2018;392(10152):1047– 57. DOI: 10.1016/S0140-6736(18)31880-4

26. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured tele phone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Coc. European Journal of Heart Failure. 2011;13(9):1028–40. DOI: 10.1093/eurjhf/hfr039

27. Grebennikova A. A., Stoliarov A. Yu., Lopatin Yu. M. The use of platform for remote monitoring on the base of mobile app for improving self-care in patients with chronic heart failure. Kardiologiia. 2017;57 (S4):11–8. DOI: 10.18087/cardio.2413

28. Loukianov M.M., Kozminsky A.N., Martsevich S.Yu., Yakushin S.S., Vorobyev A.N., Zagrebelnyy A.V. et al. Patients with Combination of Chronic Heart Failure, Hypertension and History of Myocardial Infarction: Clinical and Anamnestic Characteristics, Administration of ACE Inhibitors, Angiotensin Receptor Blockers, β-Blockers and Adherence to the Drug Therapy (Data of Outpatient Registry RECVASA). Rational Pharmacotherapy in Cardiology. 2017;13 (2):207–12. DOI: 10.20996/1819-6446-2017-13-2-207-212

29. Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF et al. Effectiveness of the European Society of Cardiology/Heart Failure Association website ‘heartfailurematters.org’ and an e-health adjusted care pathway in patients with stable heart failure: results of the ‘e-Vita HF’ randomized controlled trial: E-health tools in heart failure: e-Vita HF study. European Journal of Heart Failure. 2019;21(2):238–46. DOI: 10.1002/ ejhf.1354

30. Stepina E.V., Lukyanov M.M., Boytsov S.A., Bichurina M.A., Belova E.N., Kudryashov E.V. et al. Prescription of medications influencing prognosis in atrial fibrillation with arterial hypertension, coronary heart disease, chronic heart failure, by the registry REKVAZA-CLINIC. Cardiovascular Therapy and Prevention. 2017;16 (2):33–8. DOI: 10.15829/1728-8800-2017-2-33-38

31. Obermeyer Z, Lee TH. Lost in Thought — The Limits of the Human Mind and the Future of Medicine. New England Journal of Medicine. 2017;377(13):1209–11. DOI: 10.1056/NEJMp1705348

32. Grange J. The role of nurses in the management of heart failure. Heart. 2005;91(suppl_2):ii39–42. DOI: 10.1136/hrt.2005.062117

33. Puskarich MA, Callaway C, Silbergleit R, Pines JM, Obermeyer Z, Wright DW et al. Priorities to Overcome Barriers Impacting Data Science Application in Emergency Care Research. Academic Emergency Medicine. 2018;26(1):97–105. DOI: 10.1111/ acem.13520

34. Dierckx R, Inglis SC, Clark RA, Prieto-Merino D, Cleland JGF. Telemedicine in heart failure: new insights from the Cochrane meta-analyses: Viewpoint. European Journal of Heart Failure. 2017;19(3):304–6. DOI: 10.1002/ejhf.759

35. McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology. 2004;44(4):810–9. DOI: 10.1016/j.jacc.2004.05.055

36. Cleland JGF, Louis AA, Rigby AS, Janssens U, Balk AHMM. Noninvasive Home Telemonitoring for Patients with Heart Failure at High Risk of Recurrent Admission and Death. Journal of the American College of Cardiology. 2005;45(10):1654–64. DOI: 10.1016/j.jacc.2005.01.050

37. Dierckx R, Pellicori P, Cleland JGF, Clark AL. Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews. 2015;20(1):107–16. DOI: 10.1007/s10741-014-9449-4.

38. Dierckx R, Cleland JG, Pellicori P, Zhang J, Goode K, Putzu P et al. If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare. 2015;21(6):331–9. DOI: 10.1177/1357633X15574947

39. British society for heart failure. National Heart Failure Audit april 2013 – march 2014. Av. at: http://www.ucl.ac.uk/nicor/audits/ heartfailure/documents/annualreports/hfannual13-14.pdf. 2014.

40. Giordano A, Scalvini S, Zanelli E, Corrà U, G.L. L, Ricci VA et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. International Journal of Cardiology. 2009;131(2):192–9. DOI: 10.1016/j.ijcard.2007.10.027

41. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M et al. Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients with Chronic Heart Failure: The Telemedical Interventional Monitoring in Heart Failure Study. Circulation. 2011;123(17):1873–80. DOI: 10.1161/ CIRCULATIONAHA.111.018473

42. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z et al. Telemonitoring in patients with heart failure. The New England Journal of Medicine. 2010;363(24):2301–9. DOI: 10.1056/ NEJMoa1010029

43. Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews. 2015;10:CD007228. DOI: 10.1002/14651858. CD007228.pub3

44. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients with Heart Failure: The Bet¬¬ter Effectiveness After Transition–Heart Failure (BEATHF) Randomized Clinical Trial. JAMA Internal Medicine. 2016;176(3):310–8. DOI: 10.1001/jamainternmed.2015.7712

45. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treat ment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/ eurheartj/ehw128

46. Lynga P, Persson H, Hägg-Martinell A, Hägglund E, Hagerman I, Langius-Eklöf A et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. European Journal of Heart Failure. 2012;14(4):438–44. DOI: 10.1093/eur jhf/hfs023

47. Mareev V.Yu., Begrambekova Yu.L., Danielyan M.O., Ageev F.T., Gilyarevskiy S.R., Belenkov Yu.N. et al. What questions are asked and answered by studies of non-drug treatment in patients with heart failure. Lessons from the CHANCE study. Russian Heart Failure Journal. 2014;15 (6):383–96.

48. Mortara A, Pinna GD, Johnson P, Maestri R, Capomolla S, La Rovere MT et al. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure). European Journal of Heart Failure. 2009;11(3):312–8. DOI: 10.1093/eurjhf/hfp022

49. Boyne JJJ, Vrijhoef HJM, Crijns HJGM, De Weerd G, Kragten J, Gorgels APM et al. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. European Journal of Heart Failure. 2012;14(7):791–801. DOI: 10.1093/eurjhf/hfs058

50. Soran OZ, Piña IL, Lamas GA, Kelsey SF, Selzer F, Pilotte J et al. A Randomized Clinical Trial of the Clinical Effects of Enhanced Heart Failure Monitoring Using a Computer-Based Telephonic Monitoring System in Older Minorities and Women. Journal of Cardiac Failure. 2008;14(9):711–7. DOI: 10.1016/j.card fail.2008.06.448

51. Vasilevskis EE, Kripalani S, Ong MK, Rosenthal JT, Longnecker DE, Harmon B et al. Variability in Implementation of Interventions Aimed at Reducing Readmissions Among Patients with Heart Failure: A Survey of Teaching Hospitals. Academic Medicine. 2016;91(4):522–9. DOI: 10.1097/ACM.0000000000000994

52. Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B-A et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. The Lancet. 2018;392(10152):1047– 57. DOI: 10.1016/S0140-6736(18)31880-4

53. Grebennikova A. A., Stoliarov A. Yu., Lopatin Yu. M. The use of platform for remote monitoring on the base of mobile app for improving self-care in patients with chronic heart failure. Kardiologiia. 2017;57 (S4):11–8. DOI: 10.18087/cardio.2413

54. Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF et al. Effectiveness of the European Society of Cardiology/Heart Failure Association website ‘heartfailurematters.org’ and an e-health adjusted care pathway in patients with stable heart failure: results of the ‘e-Vita HF’ randomized controlled trial: E-health tools in heart failure: e-Vita HF study. European Journal of Heart Failure. 2019;21(2):238–46. DOI: 10.1002/ ejhf.1354

55. Obermeyer Z, Lee TH. Lost in Thought — The Limits of the Human Mind and the Future of Medicine. New England Journal of Medicine. 2017;377(13):1209–11. DOI: 10.1056/NEJMp1705348

56. Puskarich MA, Callaway C, Silbergleit R, Pines JM, Obermeyer Z, Wright DW et al. Priorities to Overcome Barriers Impacting Data Science Application in Emergency Care Research. Academic Emergency Medicine. 2018;26(1):97–105. DOI: 10.1111/ acem.13520

57. McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology. 2004;44(4):810–9. DOI: 10.1016/j.jacc.2004.05.055

58. Dierckx R, Pellicori P, Cleland JGF, Clark AL. Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews. 2015;20(1):107–16. DOI: 10.1007/s10741-014-9449-4.